Chapter
Developing mass market testing for regenerative medicine
1:22:41 - 1:27:50 (05:08)
The long-term goal for regenerative medicine is to find a method for mass-market use which could be something like a pill or a shot. This platform facilitates testing with different cell types and tissues to develop therapies for different indications.
Clips
New Limit is creating a platform to test the combination of transcription factors in different cell types, using machine learning to hone in on optimal combinations for producing certain changes in the cells.
1:22:41 - 1:25:07 (02:26)
Summary
New Limit is creating a platform to test the combination of transcription factors in different cell types, using machine learning to hone in on optimal combinations for producing certain changes in the cells. This could have a wide range of applications, from regenerating organs to creating more effective cancer treatments.
ChapterDeveloping mass market testing for regenerative medicine
Episode#627: Brian Armstrong, CEO of Coinbase — The Art of Relentless Focus, Preparing for Full-Contact Entrepreneurship, Critical Forks in the Path, Handling Haters, The Wisdom of Paul Graham, Epigenetic Reprogramming, and Much More
PodcastThe Tim Ferriss Show
Researchers are developing a platform to test how to rejuvenate different cell types at an industrial scale, which may lead to developing therapies for different indications such as T-cells and pulmonary fibrosis.
1:25:07 - 1:27:50 (02:42)
Summary
Researchers are developing a platform to test how to rejuvenate different cell types at an industrial scale, which may lead to developing therapies for different indications such as T-cells and pulmonary fibrosis. Future treatments might be more mass-market, in the form of a pill or shot.